Detail Information of Epigenetic Regulations

General Information of Drug Transporter (DT)
DT ID	DTD0523 Transporter Info
Gene Name	CACNG2
Transporter Name	Voltage-dependent calcium channel gamma-2
Gene ID	10369
UniProt ID	Q9Y698

Epigenetic Regulations of This DT (EGR)
Methylation
Prostate cancer	3 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of CACNG2 in prostate cancer			[ 1 ]
Location	5'UTR (cg04011829)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.69E+00	Statistic Test	p-value:2.50E-03; Z-score:5.22E+00
Methylation in Case	7.11E-01 (Median)	Methylation in Control	4.22E-01 (Median)
Studied Phenotype	Prostate cancer[ ICD-11:2C82]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of CACNG2 in prostate cancer			[ 1 ]
Location	Body (cg08181642)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.16E+00	Statistic Test	p-value:1.75E-02; Z-score:9.39E+00
Methylation in Case	8.37E-01 (Median)	Methylation in Control	7.24E-01 (Median)
Studied Phenotype	Prostate cancer[ ICD-11:2C82]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of CACNG2 in prostate cancer			[ 1 ]
Location	Body (cg00161124)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.25E+00	Statistic Test	p-value:4.81E-02; Z-score:2.19E+00
Methylation in Case	7.29E-01 (Median)	Methylation in Control	5.81E-01 (Median)
Studied Phenotype	Prostate cancer[ ICD-11:2C82]
Experimental Material	Patient tissue samples
Bladder cancer	10 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of CACNG2 in bladder cancer			[ 2 ]
Location	TSS1500 (cg12451153)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.25E+00	Statistic Test	p-value:1.79E-02; Z-score:-2.10E+00
Methylation in Case	8.30E-02 (Median)	Methylation in Control	1.03E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of CACNG2 in bladder cancer			[ 2 ]
Location	TSS200 (cg17580331)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-2.04E+00	Statistic Test	p-value:2.56E-03; Z-score:-3.79E+00
Methylation in Case	1.49E-01 (Median)	Methylation in Control	3.05E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of CACNG2 in bladder cancer			[ 2 ]
Location	Body (cg15606745)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.32E+00	Statistic Test	p-value:3.80E-08; Z-score:-1.29E+01
Methylation in Case	4.59E-01 (Median)	Methylation in Control	6.06E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of CACNG2 in bladder cancer			[ 2 ]
Location	Body (cg18666630)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.95E+00	Statistic Test	p-value:6.09E-08; Z-score:-7.04E+00
Methylation in Case	3.08E-01 (Median)	Methylation in Control	6.00E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of CACNG2 in bladder cancer			[ 2 ]
Location	Body (cg18984186)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.29E+00	Statistic Test	p-value:4.83E-07; Z-score:-9.58E+00
Methylation in Case	5.59E-01 (Median)	Methylation in Control	7.23E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of CACNG2 in bladder cancer			[ 2 ]
Location	Body (cg04350355)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.23E+00	Statistic Test	p-value:2.39E-06; Z-score:-9.69E+00
Methylation in Case	6.47E-01 (Median)	Methylation in Control	7.97E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of CACNG2 in bladder cancer			[ 2 ]
Location	Body (cg06943853)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.19E+00	Statistic Test	p-value:5.21E-06; Z-score:-6.97E+00
Methylation in Case	6.80E-01 (Median)	Methylation in Control	8.10E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of CACNG2 in bladder cancer			[ 2 ]
Location	Body (cg04933168)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.24E+00	Statistic Test	p-value:3.01E-05; Z-score:-3.28E+00
Methylation in Case	5.78E-01 (Median)	Methylation in Control	7.17E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon9	Methylation of CACNG2 in bladder cancer			[ 2 ]
Location	Body (cg04186249)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.25E+00	Statistic Test	p-value:1.07E-04; Z-score:-4.73E+00
Methylation in Case	5.94E-01 (Median)	Methylation in Control	7.45E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon10	Methylation of CACNG2 in bladder cancer			[ 2 ]
Location	Body (cg17806661)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.39E+00	Statistic Test	p-value:2.43E-04; Z-score:-3.51E+00
Methylation in Case	2.52E-01 (Median)	Methylation in Control	3.49E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Breast cancer	13 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of CACNG2 in breast cancer			[ 3 ]
Location	TSS1500 (cg01151699)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.15E+00	Statistic Test	p-value:9.39E-04; Z-score:3.85E-01
Methylation in Case	4.47E-02 (Median)	Methylation in Control	3.90E-02 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of CACNG2 in breast cancer			[ 3 ]
Location	TSS1500 (cg20648240)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.21E+00	Statistic Test	p-value:4.15E-03; Z-score:8.06E-01
Methylation in Case	4.92E-02 (Median)	Methylation in Control	4.05E-02 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of CACNG2 in breast cancer			[ 3 ]
Location	TSS1500 (cg12451153)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.20E+00	Statistic Test	p-value:7.01E-03; Z-score:4.85E-01
Methylation in Case	8.61E-02 (Median)	Methylation in Control	7.18E-02 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of CACNG2 in breast cancer			[ 3 ]
Location	TSS1500 (cg08242574)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.16E+00	Statistic Test	p-value:1.76E-02; Z-score:4.10E-01
Methylation in Case	5.70E-02 (Median)	Methylation in Control	4.93E-02 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of CACNG2 in breast cancer			[ 3 ]
Location	TSS200 (cg24290616)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.33E+00	Statistic Test	p-value:1.16E-05; Z-score:1.09E+00
Methylation in Case	8.31E-02 (Median)	Methylation in Control	6.24E-02 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of CACNG2 in breast cancer			[ 3 ]
Location	Body (cg13270055)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.60E+00	Statistic Test	p-value:1.18E-24; Z-score:3.55E+00
Methylation in Case	5.90E-01 (Median)	Methylation in Control	3.70E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of CACNG2 in breast cancer			[ 3 ]
Location	Body (cg04186249)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.21E+00	Statistic Test	p-value:9.40E-12; Z-score:-2.56E+00
Methylation in Case	5.71E-01 (Median)	Methylation in Control	6.94E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of CACNG2 in breast cancer			[ 3 ]
Location	Body (cg18666630)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.19E+00	Statistic Test	p-value:3.72E-08; Z-score:-1.65E+00
Methylation in Case	4.58E-01 (Median)	Methylation in Control	5.46E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon9	Methylation of CACNG2 in breast cancer			[ 3 ]
Location	Body (cg15606745)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.03E+00	Statistic Test	p-value:1.57E-04; Z-score:-6.35E-01
Methylation in Case	5.63E-01 (Median)	Methylation in Control	5.81E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon10	Methylation of CACNG2 in breast cancer			[ 3 ]
Location	Body (cg04933168)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.08E+00	Statistic Test	p-value:3.59E-03; Z-score:1.00E+00
Methylation in Case	6.90E-01 (Median)	Methylation in Control	6.36E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon11	Methylation of CACNG2 in breast cancer			[ 3 ]
Location	Body (cg04350355)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.07E+00	Statistic Test	p-value:7.75E-03; Z-score:9.87E-01
Methylation in Case	7.13E-01 (Median)	Methylation in Control	6.64E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon12	Methylation of CACNG2 in breast cancer			[ 3 ]
Location	Body (cg22496723)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.03E+00	Statistic Test	p-value:2.58E-02; Z-score:5.10E-01
Methylation in Case	8.30E-01 (Median)	Methylation in Control	8.05E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon13	Methylation of CACNG2 in breast cancer			[ 3 ]
Location	Body (cg18984186)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.06E+00	Statistic Test	p-value:4.21E-02; Z-score:-7.65E-01
Methylation in Case	6.62E-01 (Median)	Methylation in Control	7.02E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Colorectal cancer	15 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	TSS1500 (cg01151699)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.07E+00	Statistic Test	p-value:1.72E-05; Z-score:-3.10E-01
Methylation in Case	8.97E-02 (Median)	Methylation in Control	9.57E-02 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	TSS1500 (cg12451153)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.07E+00	Statistic Test	p-value:6.77E-04; Z-score:2.62E-01
Methylation in Case	1.51E-01 (Median)	Methylation in Control	1.41E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	TSS1500 (cg08242574)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.04E+00	Statistic Test	p-value:2.83E-03; Z-score:1.60E-01
Methylation in Case	1.48E-01 (Median)	Methylation in Control	1.43E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	TSS1500 (cg20648240)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.03E+00	Statistic Test	p-value:6.80E-03; Z-score:-1.10E-01
Methylation in Case	5.71E-02 (Median)	Methylation in Control	5.90E-02 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	TSS200 (cg04191954)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.03E+00	Statistic Test	p-value:1.89E-05; Z-score:1.75E-01
Methylation in Case	2.17E-01 (Median)	Methylation in Control	2.10E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	TSS200 (cg17580331)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.19E+00	Statistic Test	p-value:2.24E-03; Z-score:1.68E+00
Methylation in Case	5.69E-01 (Median)	Methylation in Control	4.78E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	TSS200 (cg24290616)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.06E+00	Statistic Test	p-value:4.25E-03; Z-score:-2.34E-01
Methylation in Case	2.35E-01 (Median)	Methylation in Control	2.49E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	Body (cg17806661)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.41E+00	Statistic Test	p-value:3.25E-14; Z-score:-3.40E+00
Methylation in Case	4.79E-01 (Median)	Methylation in Control	6.78E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon9	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	Body (cg15606745)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.24E+00	Statistic Test	p-value:2.01E-13; Z-score:-3.10E+00
Methylation in Case	5.33E-01 (Median)	Methylation in Control	6.64E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon10	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	Body (cg04186249)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.18E+00	Statistic Test	p-value:3.18E-13; Z-score:-5.02E+00
Methylation in Case	7.27E-01 (Median)	Methylation in Control	8.61E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon11	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	Body (cg06943853)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.13E+00	Statistic Test	p-value:5.49E-10; Z-score:-3.52E+00
Methylation in Case	7.45E-01 (Median)	Methylation in Control	8.42E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon12	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	Body (cg18984186)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.06E+00	Statistic Test	p-value:5.11E-09; Z-score:-2.86E+00
Methylation in Case	7.94E-01 (Median)	Methylation in Control	8.44E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon13	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	Body (cg04350355)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.07E+00	Statistic Test	p-value:5.06E-07; Z-score:-3.33E+00
Methylation in Case	8.20E-01 (Median)	Methylation in Control	8.80E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon14	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	Body (cg04933168)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.03E+00	Statistic Test	p-value:1.42E-03; Z-score:-8.53E-01
Methylation in Case	8.30E-01 (Median)	Methylation in Control	8.55E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon15	Methylation of CACNG2 in colorectal cancer			[ 4 ]
Location	Body (cg18666630)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.18E+00	Statistic Test	p-value:1.82E-03; Z-score:-8.33E-01
Methylation in Case	4.35E-01 (Median)	Methylation in Control	5.14E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Hepatocellular carcinoma	14 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	TSS1500 (cg05159370)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.45E+00	Statistic Test	p-value:2.80E-11; Z-score:-3.23E+00
Methylation in Case	4.09E-01 (Median)	Methylation in Control	5.93E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	TSS1500 (cg12451153)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.13E+00	Statistic Test	p-value:2.11E-05; Z-score:4.92E-01
Methylation in Case	1.59E-01 (Median)	Methylation in Control	1.41E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	TSS1500 (cg01151699)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.24E+00	Statistic Test	p-value:2.38E-05; Z-score:1.05E+00
Methylation in Case	8.01E-02 (Median)	Methylation in Control	6.49E-02 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	TSS1500 (cg20648240)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.08E+00	Statistic Test	p-value:5.67E-03; Z-score:3.08E-01
Methylation in Case	6.61E-02 (Median)	Methylation in Control	6.11E-02 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	TSS1500 (cg08242574)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.10E+00	Statistic Test	p-value:5.90E-03; Z-score:2.22E-01
Methylation in Case	9.60E-02 (Median)	Methylation in Control	8.76E-02 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	TSS200 (cg25212131)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.24E+00	Statistic Test	p-value:4.15E-18; Z-score:2.62E+00
Methylation in Case	8.21E-01 (Median)	Methylation in Control	6.65E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	TSS200 (cg04191954)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.03E+00	Statistic Test	p-value:5.31E-03; Z-score:-1.69E-01
Methylation in Case	1.04E-01 (Median)	Methylation in Control	1.08E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	Body (cg23368787)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.38E+00	Statistic Test	p-value:2.74E-15; Z-score:2.94E+00
Methylation in Case	6.12E-01 (Median)	Methylation in Control	4.43E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon9	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	Body (cg12848639)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.36E+00	Statistic Test	p-value:2.08E-13; Z-score:-5.62E+00
Methylation in Case	5.06E-01 (Median)	Methylation in Control	6.86E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon10	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	Body (cg12072789)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.30E+00	Statistic Test	p-value:2.37E-10; Z-score:-2.07E+00
Methylation in Case	4.77E-01 (Median)	Methylation in Control	6.19E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon11	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	Body (cg04437482)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.24E+00	Statistic Test	p-value:9.24E-10; Z-score:-2.25E+00
Methylation in Case	5.57E-01 (Median)	Methylation in Control	6.89E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon12	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	Body (cg18984186)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.05E+00	Statistic Test	p-value:3.13E-05; Z-score:-1.13E+00
Methylation in Case	6.75E-01 (Median)	Methylation in Control	7.12E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon13	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	Body (cg22496723)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.09E+00	Statistic Test	p-value:2.82E-03; Z-score:-1.14E+00
Methylation in Case	7.20E-01 (Median)	Methylation in Control	7.87E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon14	Methylation of CACNG2 in hepatocellular carcinoma			[ 5 ]
Location	Body (cg13270055)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.11E+00	Statistic Test	p-value:5.54E-03; Z-score:-6.92E-01
Methylation in Case	4.53E-01 (Median)	Methylation in Control	5.03E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Lung adenocarcinoma	6 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of CACNG2 in lung adenocarcinoma			[ 6 ]
Location	TSS1500 (cg08242574)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.34E+00	Statistic Test	p-value:4.26E-03; Z-score:1.28E+00
Methylation in Case	1.44E-01 (Median)	Methylation in Control	1.07E-01 (Median)
Studied Phenotype	Lung adenocarcinoma[ ICD-11:2C25.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of CACNG2 in lung adenocarcinoma			[ 6 ]
Location	TSS1500 (cg01151699)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.44E+00	Statistic Test	p-value:3.15E-02; Z-score:2.27E+00
Methylation in Case	1.13E-01 (Median)	Methylation in Control	7.85E-02 (Median)
Studied Phenotype	Lung adenocarcinoma[ ICD-11:2C25.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of CACNG2 in lung adenocarcinoma			[ 6 ]
Location	Body (cg04933168)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.09E+00	Statistic Test	p-value:9.86E-03; Z-score:1.33E+00
Methylation in Case	7.91E-01 (Median)	Methylation in Control	7.23E-01 (Median)
Studied Phenotype	Lung adenocarcinoma[ ICD-11:2C25.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of CACNG2 in lung adenocarcinoma			[ 6 ]
Location	Body (cg18666630)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.12E+00	Statistic Test	p-value:1.76E-02; Z-score:-2.01E+00
Methylation in Case	5.57E-01 (Median)	Methylation in Control	6.21E-01 (Median)
Studied Phenotype	Lung adenocarcinoma[ ICD-11:2C25.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of CACNG2 in lung adenocarcinoma			[ 6 ]
Location	Body (cg13270055)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.16E+00	Statistic Test	p-value:4.07E-02; Z-score:9.07E-01
Methylation in Case	7.18E-01 (Median)	Methylation in Control	6.18E-01 (Median)
Studied Phenotype	Lung adenocarcinoma[ ICD-11:2C25.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of CACNG2 in lung adenocarcinoma			[ 6 ]
Location	Body (cg15606745)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.04E+00	Statistic Test	p-value:4.71E-02; Z-score:-1.54E+00
Methylation in Case	5.73E-01 (Median)	Methylation in Control	5.97E-01 (Median)
Studied Phenotype	Lung adenocarcinoma[ ICD-11:2C25.0]
Experimental Material	Patient tissue samples
Pancretic ductal adenocarcinoma	10 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of CACNG2 in pancretic ductal adenocarcinoma			[ 7 ]
Location	TSS1500 (cg14918082)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.20E+00	Statistic Test	p-value:7.40E-04; Z-score:-1.08E+00
Methylation in Case	5.87E-01 (Median)	Methylation in Control	7.03E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of CACNG2 in pancretic ductal adenocarcinoma			[ 7 ]
Location	TSS1500 (cg10508416)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.06E+00	Statistic Test	p-value:1.52E-03; Z-score:-7.08E-01
Methylation in Case	7.54E-01 (Median)	Methylation in Control	8.02E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of CACNG2 in pancretic ductal adenocarcinoma			[ 7 ]
Location	TSS1500 (cg26904702)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.04E+00	Statistic Test	p-value:9.54E-03; Z-score:-6.14E-01
Methylation in Case	7.18E-01 (Median)	Methylation in Control	7.44E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of CACNG2 in pancretic ductal adenocarcinoma			[ 7 ]
Location	TSS200 (cg15014549)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.10E+00	Statistic Test	p-value:2.88E-09; Z-score:5.61E-01
Methylation in Case	1.01E-01 (Median)	Methylation in Control	9.19E-02 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of CACNG2 in pancretic ductal adenocarcinoma			[ 7 ]
Location	TSS200 (cg18771173)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.52E+00	Statistic Test	p-value:5.33E-05; Z-score:6.09E-01
Methylation in Case	1.22E-01 (Median)	Methylation in Control	8.03E-02 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of CACNG2 in pancretic ductal adenocarcinoma			[ 7 ]
Location	Body (cg01643580)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.21E+00	Statistic Test	p-value:1.67E-06; Z-score:1.32E+00
Methylation in Case	3.45E-01 (Median)	Methylation in Control	2.86E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of CACNG2 in pancretic ductal adenocarcinoma			[ 7 ]
Location	Body (cg06347454)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.08E+00	Statistic Test	p-value:5.57E-04; Z-score:8.57E-01
Methylation in Case	8.37E-01 (Median)	Methylation in Control	7.75E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of CACNG2 in pancretic ductal adenocarcinoma			[ 7 ]
Location	Body (cg09168805)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.05E+00	Statistic Test	p-value:1.30E-03; Z-score:3.10E-01
Methylation in Case	7.45E-01 (Median)	Methylation in Control	7.11E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon9	Methylation of CACNG2 in pancretic ductal adenocarcinoma			[ 7 ]
Location	Body (cg00706648)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.03E+00	Statistic Test	p-value:5.20E-03; Z-score:6.74E-01
Methylation in Case	7.31E-01 (Median)	Methylation in Control	7.08E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon10	Methylation of CACNG2 in pancretic ductal adenocarcinoma			[ 7 ]
Location	Body (cg24115232)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.19E+00	Statistic Test	p-value:1.95E-02; Z-score:9.12E-01
Methylation in Case	5.50E-01 (Median)	Methylation in Control	4.63E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Papillary thyroid cancer	6 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of CACNG2 in papillary thyroid cancer			[ 8 ]
Location	TSS1500 (cg12451153)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.01E+00	Statistic Test	p-value:2.17E-02; Z-score:4.76E-02
Methylation in Case	6.94E-02 (Median)	Methylation in Control	6.85E-02 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of CACNG2 in papillary thyroid cancer			[ 8 ]
Location	Body (cg04186249)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.12E+00	Statistic Test	p-value:5.67E-11; Z-score:-1.83E+00
Methylation in Case	7.32E-01 (Median)	Methylation in Control	8.17E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of CACNG2 in papillary thyroid cancer			[ 8 ]
Location	Body (cg15606745)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.04E+00	Statistic Test	p-value:6.47E-06; Z-score:-1.12E+00
Methylation in Case	5.58E-01 (Median)	Methylation in Control	5.82E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of CACNG2 in papillary thyroid cancer			[ 8 ]
Location	Body (cg18666630)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.06E+00	Statistic Test	p-value:5.97E-04; Z-score:-6.14E-01
Methylation in Case	6.73E-01 (Median)	Methylation in Control	7.11E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of CACNG2 in papillary thyroid cancer			[ 8 ]
Location	Body (cg04350355)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.02E+00	Statistic Test	p-value:9.57E-04; Z-score:-6.08E-01
Methylation in Case	8.83E-01 (Median)	Methylation in Control	9.03E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of CACNG2 in papillary thyroid cancer			[ 8 ]
Location	Body (cg06943853)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.02E+00	Statistic Test	p-value:3.76E-03; Z-score:-5.51E-01
Methylation in Case	7.74E-01 (Median)	Methylation in Control	7.89E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Renal cell carcinoma	3 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of CACNG2 in clear cell renal cell carcinoma			[ 9 ]
Location	TSS200 (cg24290616)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.42E+00	Statistic Test	p-value:4.12E-03; Z-score:8.82E-01
Methylation in Case	3.30E-02 (Median)	Methylation in Control	2.32E-02 (Median)
Studied Phenotype	Renal cell carcinoma[ ICD-11:2C90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of CACNG2 in clear cell renal cell carcinoma			[ 9 ]
Location	TSS200 (cg04191954)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.23E+00	Statistic Test	p-value:4.50E-03; Z-score:7.44E-01
Methylation in Case	4.27E-02 (Median)	Methylation in Control	3.47E-02 (Median)
Studied Phenotype	Renal cell carcinoma[ ICD-11:2C90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of CACNG2 in clear cell renal cell carcinoma			[ 9 ]
Location	Body (cg13270055)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.22E+00	Statistic Test	p-value:4.55E-03; Z-score:1.33E+00
Methylation in Case	7.52E-01 (Median)	Methylation in Control	6.15E-01 (Median)
Studied Phenotype	Renal cell carcinoma[ ICD-11:2C90]
Experimental Material	Patient tissue samples
Colon cancer	3 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of CACNG2 in colon adenocarcinoma			[ 10 ]
Location	Body (cg09150064)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.49E+00	Statistic Test	p-value:6.68E-04; Z-score:2.47E+00
Methylation in Case	3.68E-01 (Median)	Methylation in Control	2.46E-01 (Median)
Studied Phenotype	Colon cancer[ ICD-11:2B90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of CACNG2 in colon adenocarcinoma			[ 10 ]
Location	Body (cg02857074)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.26E+00	Statistic Test	p-value:7.03E-04; Z-score:-1.11E+00
Methylation in Case	3.06E-01 (Median)	Methylation in Control	3.86E-01 (Median)
Studied Phenotype	Colon cancer[ ICD-11:2B90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of CACNG2 in colon adenocarcinoma			[ 10 ]
Location	Body (cg20050113)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.27E+00	Statistic Test	p-value:7.22E-04; Z-score:-1.75E+00
Methylation in Case	3.12E-01 (Median)	Methylation in Control	3.98E-01 (Median)
Studied Phenotype	Colon cancer[ ICD-11:2B90]
Experimental Material	Patient tissue samples
Panic disorder	4 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of CACNG2 in panic disorder			[ 11 ]
Location	Body (cg17806661)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-9.04E-01	Statistic Test	p-value:1.75E-03; Z-score:-4.46E-01
Methylation in Case	-1.74E+00 (Median)	Methylation in Control	-1.58E+00 (Median)
Studied Phenotype	Panic disorder[ ICD-11:6B01]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of CACNG2 in panic disorder			[ 11 ]
Location	Body (cg04186249)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.11E+00	Statistic Test	p-value:1.09E-02; Z-score:4.76E-01
Methylation in Case	2.20E+00 (Median)	Methylation in Control	1.99E+00 (Median)
Studied Phenotype	Panic disorder[ ICD-11:6B01]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of CACNG2 in panic disorder			[ 11 ]
Location	Body (cg18666630)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.10E+00	Statistic Test	p-value:2.59E-02; Z-score:1.68E-01
Methylation in Case	7.49E-01 (Median)	Methylation in Control	6.79E-01 (Median)
Studied Phenotype	Panic disorder[ ICD-11:6B01]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of CACNG2 in panic disorder			[ 11 ]
Location	Body (cg04350355)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.07E+00	Statistic Test	p-value:3.65E-02; Z-score:4.12E-01
Methylation in Case	3.21E+00 (Median)	Methylation in Control	3.01E+00 (Median)
Studied Phenotype	Panic disorder[ ICD-11:6B01]
Experimental Material	Patient tissue samples
Chordoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Moderate hypermethylation of CACNG2 in chordoma than that in healthy individual
Studied Phenotype	Chordoma [ICD-11:5A61.0]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:0.004919165; Fold-change:0.243965097; Z-score:1.167112221
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Craniopharyngioma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Moderate hypermethylation of CACNG2 in craniopharyngioma than that in healthy individual
Studied Phenotype	Craniopharyngioma [ICD-11:2F9A]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:0.039252322; Fold-change:0.216139585; Z-score:0.8170911
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Hemangioblastoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Moderate hypermethylation of CACNG2 in hemangioblastoma than that in healthy individual
Studied Phenotype	Hemangioblastoma [ICD-11:2F7C]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:0.002515146; Fold-change:0.218404137; Z-score:0.901451947
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Lymphoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Moderate hypermethylation of CACNG2 in lymphoma than that in healthy individual
Studied Phenotype	Lymphoma [ICD-11:2B30]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:0.001330689; Fold-change:0.290423253; Z-score:1.341719306
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Esthesioneuroblastoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Moderate hypomethylation of CACNG2 in esthesioneuroblastoma than that in healthy individual
Studied Phenotype	Esthesioneuroblastoma [ICD-11:2D50.1]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:2.55E-05; Fold-change:-0.2779795; Z-score:-1.054736877
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Oligodendroglial tumour	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Moderate hypomethylation of CACNG2 in oligodendroglial tumour than that in healthy individual
Studied Phenotype	Oligodendroglial tumour [ICD-11:2A00.Y1]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:0.016533483; Fold-change:-0.209984535; Z-score:-6.052861535
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Myxopapillary ependymoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypermethylation of CACNG2 in myxopapillary ependymoma than that in healthy individual
Studied Phenotype	Myxopapillary ependymoma [ICD-11:2A00.5]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:0.000240329; Fold-change:0.390543084; Z-score:1.627029009
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Third ventricle chordoid glioma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypermethylation of CACNG2 in third ventricle chordoid glioma than that in healthy individual
Studied Phenotype	Third ventricle chordoid glioma [ICD-11:2A00.0Y]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:0.017365893; Fold-change:0.437102162; Z-score:1.445184583
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Brain neuroblastoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypomethylation of CACNG2 in brain neuroblastoma than that in healthy individual
Studied Phenotype	Brain neuroblastoma [ICD-11:2A00.11]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:1.00E-15; Fold-change:-0.450509159; Z-score:-1.820253049
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Central neurocytoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypomethylation of CACNG2 in central neurocytoma than that in healthy individual
Studied Phenotype	Central neurocytoma [ICD-11:2A00.3]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:4.04E-06; Fold-change:-0.505035521; Z-score:-1.821621963
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Cerebellar liponeurocytoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypomethylation of CACNG2 in cerebellar liponeurocytoma than that in healthy individual
Studied Phenotype	Cerebellar liponeurocytoma [ICD-11:2A00.0Y]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:2.76E-06; Fold-change:-0.407967686; Z-score:-1.417846546
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Diffuse midline glioma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypomethylation of CACNG2 in diffuse midline glioma than that in healthy individual
Studied Phenotype	Diffuse midline glioma [ICD-11:2A00.0Z]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:1.85E-24; Fold-change:-0.349307513; Z-score:-1.763618271
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Low grade glioma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypomethylation of CACNG2 in low grade glioma than that in healthy individual
Studied Phenotype	Low grade glioma [ICD-11:2A00.0Z]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:5.18E-27; Fold-change:-0.329267941; Z-score:-1.741185023
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Malignant astrocytoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypomethylation of CACNG2 in malignant astrocytoma than that in healthy individual
Studied Phenotype	Malignant astrocytoma [ICD-11:2A00.12]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:8.98E-15; Fold-change:-0.322497683; Z-score:-1.707798997
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Medulloblastoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypomethylation of CACNG2 in medulloblastoma than that in healthy individual
Studied Phenotype	Medulloblastoma [ICD-11:2A00.10]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:4.84E-51; Fold-change:-0.600352582; Z-score:-2.834401359
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Mixed neuronal-glial tumour	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypomethylation of CACNG2 in mixed neuronal-glial tumour than that in healthy individual
Studied Phenotype	Mixed neuronal-glial tumour [ICD-11:2A00.21]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:4.86E-15; Fold-change:-0.332964324; Z-score:-1.441868379
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Oligodendroglioma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypomethylation of CACNG2 in oligodendroglioma than that in healthy individual
Studied Phenotype	Oligodendroglioma [ICD-11:2A00.0Y]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:4.07E-29; Fold-change:-0.511137634; Z-score:-2.359240886
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual

References
1	Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
2	DNA Methylation Dynamics in Urological Tumors.
3	Genome-wide Scan for Methylation Profiles in Breast Cancer
4	Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
5	Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
6	DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
7	Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
8	Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
9	A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
10	Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
11	DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.

Detail Information of Epigenetic Regulations

Visitor Map

Correspondence